TPD52L2 and central nervous system cancer: CLTA and TPD52L2 had clear, verifiable glioma-specific splicing patterns by both exon array and RT-PCR (Figure 2A, 2B and 3B; see Additional files 7 and 8); they were also listed in one of these reports [18].